ClinicalTrials.Veeva

Menu
M

Medical Center Artmed OOD | Plovdiv, Bulgaria

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Denosumab
Cenerimod
HZN-1116

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).

Enrolling
Sjogren's Syndrome
Drug: HZN-1116
Drug: Placebo

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Enrolling
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

The main purpose of this study is to evaluate the effect and safety of efgartigimod PH20 SC compared to placebo in adults with systemic sclerosis. Th...

Enrolling
Systemic Sclerosis (SSc)
Combination Product: Efgartigimod PH20 SC
Other: Placebo PH20 SC

Trial sponsors

Amgen logo
Idorsia Pharmaceuticals logo
argenx logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems